Radu Constantinescu

Summary

Affiliation: University of Rochester
Country: USA

Publications

  1. ncbi Malignant melanoma in early Parkinson's disease: the DATATOP trial
    Radu Constantinescu
    Department of Neurology, University of Rochester Medical Center, Rochester, NY 14620, USA
    Mov Disord 22:720-2. 2007
  2. ncbi Impact of pramipexole on the onset of levodopa-related dyskinesias
    Radu Constantinescu
    Department of Neurology, University of Rochester Medical Center, Rochester, New York, USA
    Mov Disord 22:1317-9. 2007
  3. ncbi The relationship between CAG repeat length and clinical progression in Huntington's disease
    Bernard Ravina
    Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA
    Mov Disord 23:1223-7. 2008
  4. ncbi Levodopa responsiveness in disorders with parkinsonism: a review of the literature
    Radu Constantinescu
    Department of Neurology, University of Rochester School of Medicine, Rochester, New York, USA
    Mov Disord 22:2141-8; quiz 2295. 2007
  5. ncbi A randomized study of the bioavailability of different formulations of coenzyme Q(10) (ubiquinone)
    Radu Constantinescu
    Department of Neurology, Clinical Trials Coordination Center, University of Rochester Medical Center, Rochester, New York, USA
    J Clin Pharmacol 47:1580-6. 2007
  6. ncbi Assistive devices for gait in Parkinson's disease
    Radu Constantinescu
    Department of Neurology, University of Rochester School of Medicine, 1351 Mt Hope Avenue, Suite 100, Rochester, NY 14620 3917, USA
    Parkinsonism Relat Disord 13:133-8. 2007

Detail Information

Publications6

  1. ncbi Malignant melanoma in early Parkinson's disease: the DATATOP trial
    Radu Constantinescu
    Department of Neurology, University of Rochester Medical Center, Rochester, NY 14620, USA
    Mov Disord 22:720-2. 2007
    ..The standardized event ratio was 3.3 (95% confidence interval, 1.1-7.8), indicating that incidence of malignant melanoma was higher than expected. We found no association between levodopa therapy and the incidence of melanoma...
  2. ncbi Impact of pramipexole on the onset of levodopa-related dyskinesias
    Radu Constantinescu
    Department of Neurology, University of Rochester Medical Center, Rochester, New York, USA
    Mov Disord 22:1317-9. 2007
    ....
  3. ncbi The relationship between CAG repeat length and clinical progression in Huntington's disease
    Bernard Ravina
    Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA
    Mov Disord 23:1223-7. 2008
    ..This finding may account for the variable results from previous studies examining CAGn and progression. Adjusting for CAGn may be important for clinical trials...
  4. ncbi Levodopa responsiveness in disorders with parkinsonism: a review of the literature
    Radu Constantinescu
    Department of Neurology, University of Rochester School of Medicine, Rochester, New York, USA
    Mov Disord 22:2141-8; quiz 2295. 2007
    ..Efforts should be directed toward better defining LR when used for diagnostic purposes and in scientific publications...
  5. ncbi A randomized study of the bioavailability of different formulations of coenzyme Q(10) (ubiquinone)
    Radu Constantinescu
    Department of Neurology, Clinical Trials Coordination Center, University of Rochester Medical Center, Rochester, New York, USA
    J Clin Pharmacol 47:1580-6. 2007
  6. ncbi Assistive devices for gait in Parkinson's disease
    Radu Constantinescu
    Department of Neurology, University of Rochester School of Medicine, 1351 Mt Hope Avenue, Suite 100, Rochester, NY 14620 3917, USA
    Parkinsonism Relat Disord 13:133-8. 2007
    ..We review the available literature and provide practical information about available mobility assistive devices for patients with PD...